Sign up to save your podcasts
Or
Share Recently Approved Drugs: Pembrolizumab for cHL
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Recently Approved Drugs: Pembrolizumab for cHL
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
View all episodes
By American Society of Clinical Oncology (ASCO)
4.5
3131 ratings
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
More shows like ASCO Education
View all
NEJM This Week
321 Listeners
Journal of Clinical Oncology (JCO) Podcast
39 Listeners
JCO Oncology Practice Podcast
17 Listeners
ASCO Daily News
59 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
ASCO Guidelines
46 Listeners
The Readout Loud
337 Listeners
OncLive® On Air
23 Listeners
Money Meets Medicine
227 Listeners
Oncology Today with Dr Neil Love
59 Listeners
The Foreign Affairs Interview
496 Listeners
Not Otherwise Specified
63 Listeners
Two Onc Docs
195 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
45 Listeners
The Best People with Nicolle Wallace
4,433 Listeners